Почетна › Плоскоклеточни карцином главе и врата › Merilend › Baltimore
Kliničke studije za Плоскоклеточни карцином главе и врата u gradu Baltimore, MD
17 studija za Плоскоклеточни карцином главе и врата traži učesnike na lokacijama u gradu Baltimore i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Тражи се учесникФаза 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 ми удаљено
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Тражи се учесникФаза 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Тражи се учесникФаза 2
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- Baltimore Washington Medical Center- Tate Cancer Center, Glen Burnie · 9 ми удаљено
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Тражи се учесникФаза 1/2
- University of Maryland School of Medicine, Baltimore
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Тражи се учесникФаза 3
- University of Maryland Greenebaum Cancer Center, Baltimore
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Тражи се учесникФаза 2/3
- University of Maryland Medical Group (Site #0112), Baltimore
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Тражи се учесникФаза 3
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
- Greater Baltimore Medical Center, Baltimore
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #14, Baltimore
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Тражи се учесникФаза 2
- Greater Baltimore Medical Center, Baltimore
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 2
- Research Site, Baltimore
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Тражи се учесникОпсервациона студија
- University of Maryland, Baltimore
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Тражи се учесникФаза 2
- Greater Baltimore Medical Center, Baltimore
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Тражи се учесникФаза 1
- Johns Hopkins Hospital /ID# 254056, Baltimore
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Тражи се учесникФаза 3
- University of Maryland, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Тражи се учесникФаза 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Тражи се учесникФаза 2
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · 9 ми удаљено
- и још 1
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Тражи се учесникФаза 1/2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Studije za Плоскоклеточни карцином главе и врата u drugim gradovima
- Houston, TX49 студија
- Nashville, TN43 студија
- Los Angeles, CA43 студија
- Boston, MA42 студија
- New York City, NY42 студија
- St. Louis, MO32 студија
- Chicago, IL29 студија
- Arlington, VA29 студија
- Philadelphia, PA25 студија
- Pittsburgh, PA23 студија
- Atlanta, GA22 студија
- New Haven, CT22 студија
Ostale studije u gradu Baltimore
- Немалоклетни карцином плућа60 студија
- Рак простате45 студија
- Рак дојке44 студија
- Рак плућа41 студија
- Рак (све врсте)36 студија
- Колоректални карцином30 студија
- Рак панкреаса30 студија
- Метастатски карцином26 студија
- Гојазност24 студија
- Рак бешике24 студија
- Рак јајника23 студија
- Затајење срца23 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.